In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PPL Therapeutics PLC

www.ppl-therapeutics.com

Latest From PPL Therapeutics PLC

Biotech or Bank?

A look at twenty European biotech companies' cash holdings as a percentage of their market values. Thanks to strengthening investor sentiment in European biotech, certain firms are enjoying bumper years, while others continue to slump with market caps below the value of their cash holdings.
BioPharmaceutical Europe

Pharming: Back from the Brink of Bankruptcy

Two years ago it looked as if all was lost at Pharming: escalating costs for its Pompe's disease program and indebtedness to its JV partner Genzyme forced it into legal moratorium in August 2001. Today, Pharming's back in the game; indeed, its new management, slimmed down operations and heightened focus on cost control mirrors the many other European biotechs trying to adapt to the harsh winter. But Pharming could have avoided near death by not turning its development partner into its biggest creditor. Still, the firm's turnaround-even this far-shows a reassuring willingness among Europe's investors to assume risk and give companies another chance.
BioPharmaceutical Europe

ReNeuron: Going Private

VCs don't usually buy back portfolio companies once they've floated. But Merlin's offer to take struggling stem-cell group ReNeuron back into the private realm gives shareholders a slightly less unattractive deal than liquidation, even though the group is still valued below cash. More importantly, it gives ReNeuron another shot.
BioPharmaceutical Europe

Recent Dealmaking (05/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
    • Transgenics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • PPL Therapeutics PLC
  • Senior Management
  • Richard J Cruse, Dir., Fin. & CFO
    Martyn Breeze, PhD, Dir., Product Dev.
    Adam Christie, Dir., Bus. Dev.
  • Contact Info
  • PPL Therapeutics PLC
    Phone: (44) 13 14 40 47 77
    Roslin Midlothian
    Edinburgh, EH25 9PP
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register